Skip to content
Clinical Trials for Alzheimer's Disease

Iowa

Alzheimer's disease clinical trials in Iowa

3 Alzheimer's disease studies are recruiting participants at sites in 2 cities across Iowa as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Iowa city with a recruiting study

Iowa City (2), Waterloo (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Iowa

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Waterloo
    Registry record
    NCT07602582 · updated
  2. Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging

    • No phase
    • Ages 56 to 85
    • All sexes
    Sponsor
    Natalie Denburg
    Recruiting in
    Iowa City
    Registry record
    NCT03954899 · updated
  3. E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app

    • No phase
    • Ages 18 to 100
    • All sexes
    Sponsor
    University of Iowa
    Recruiting in
    Iowa City
    Registry record
    NCT07032350 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Iowa on ClinicalTrials.gov.

Ask about studies in Iowa

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call